Placeholder

2011 PharmaVOICE 100 – Who’s on the List by Company

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Acorda Therapeutics — Andrew Blight, Ph.D.
ACT Biotech Inc.— Ali Fattaey, Ph.D.
Acucela Inc.— Ryo Kubota, M.D., Ph.D.
Alliance Healthcare Information LLC— Mary Anne Greenberg
Almac Group— Sir Allen McClay
The Avoca Group Inc.— Patricia Leuchten
AXON US— Mario Nacinovich
Beardsworth Group— Donna Beardsworth
Benchmark Research— Mark Lacy
Blue Chip Healthcare Marketing— Neil Weisman
Bristol-Myers Squibb— Michael Castagna, Pharm.D.
Bristol-Myers Squibb— Sarah Wharmby
Catabasis Pharmaceuticals— Michael Jirousek, Ph.D.
Cegedim Compliance Solutions— William Buzzeo
Cempra Pharmaceuticals— Prabhavathi Fernandes
Centerphase Solutions Inc.— Beth Harper
Cephalon Inc.— Frank Baldino Jr., Ph.D.
ClearPoint— Philip McCrea
Clinica Responsable Operativa— Marlene Llopiz, M.D.
Clinical Practice Insights LLC— Tiffany Patrick
ClinStar— David Passov
closerlook inc.— David Ormesher
Compass IRB LLC— Matthew Baker
Cordis Corp., a J&J company— Ryan Saadi, M.D.
Core Principle Solutions— Pam Rattananont Ferris
CryerHealth— Donna Cryer
Dudnyk— Frank Powers
Duke Clinical Research Institute— Elizabeth Reid
eClinical Solutions— Katrina Rice
Eli Lilly and Co.— John Lechleiter, Ph.D.
EMD Serono— Howard Mayer, M.D.
Euro RSCG Life Catapult— Jeffrey Hoffman
evoke interaction — B. Reid Connolly
Exelixis — Fran Heller
Flaum Idea Group— Sander Flaum
Frestedt Inc.— Joy Frestedt
GeoVax Inc.— Harriet Robinson, Ph.D.
GlaxoSmithKline— Alex Lancksweert
GlaxoSmithKline— Philip Priest
GlaxoSmithKline— Darielle Ruderman
GSW Worldwide— Joseph Daley
Harrison and Star— Tyrone Curran
Healthcare Regional Marketing— Scott Weintraub
Healogix — Harris Kaplan
Histogen — Gail Naughton, Ph.D.
Hospira Inc.— Sumant Ramachandra, M.D., Ph.D.
i3 — Gregg Dearhammer
ICON Clinical Research — Bill Taaffe
IDEA Pharma— Mike Rea
INC Research— Javier Revuelta Pérez, Ph.D.
Inclinix — Linda Goldman
Infinity Pharmaceuticals — Julian Adams, Ph.D.
Johnson & Johnson— Lars Merk
Kendle — Stephen Cutler, Ph.D.
MCS Healthcare
Public Relations— Calep A. (Joe) Boyd III
MediciGlobal— Duncan Shaw
Medidata Solutions— Andrew Newbigging
Medimix International— Henry Gazay
MedImmune— Tristan Vaughan, Ph.D.
MedImmune — Gail Wasserman, Ph.D.
MicroMass Communications — Alyson Connor
Millennium: The Takeda Oncology Company— Joseph Bolen, Ph.D.
Molecular Profiles Ltd.— Nikin Patel
Novartis— Joe Jimenez
Novartis AG — Kim Stratton
Oceana Therapeutics Inc.— David Tierney, M.D.
Ogilvy CommonHealth Medical Marketing— Darlene Dobry
Onyx Pharmaceuticals— N. Anthony Coles, M.D.
Palio — Uwe Tigör, M.D.
The Patient Recruiting Agency — Lance Nickens
PDR Network— Edward Fotsch, M.D.
Pennsylvania Biotechnology Center — Timothy Block, Ph.D.
Pfizer Inc.— Freda Lewis-Hall, M.D.
PhamaLink Inc.— Ahsan Awan
PHT Corp.— Philip Lee
PPD— Henrietta Ukwu, M.D.
Prism Ideas— James Sawyer, MBChB
Publicis Touchpoint Solutions— Rick Keefer
Purdue Pharma LP— Mitchell Katz, Ph.D.
Qforma — Roger Jones, Ph.D.
QualityHealth — Robert Rebak
Quintiles Inc.— Amir Kalali, M.D.
RCW McCann Healthcare— Jeff Sweeney
Roska Healthcare Advertising— Kurt Mueller
Sanofi— Dennis Urbaniak
Sanofi— Christopher Viehbacher
Seaside Therapeutics— Randall Carpenter, M.D.
Shire Human Genetic Therapies — Sylvie Grégoire, Pharm.D.
The Snow Companies— Nadine McGowan
The Snow Companies — Michael Simone
Spaulding Clinical— Yolanda Davis
Stiefel, a GSK company — William Humphries
Sunovion Pharmaceuticals — Nobuhiko Tamura
Synergistix — Don Schenker
Teva Women’s Health— Keeshia Muhammad
TGaS Advisors— James Mercante
Torre Lazur Healthcare Group— Mark Willmann
United BioSource Corp.— Annette Stemhagen, Dr.PH
Veeva Vault— Jennifer Goldsmith
Vertex Pharmaceuticals— Fredrick Van Goor, Ph.D.

FEEDBACK